Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Altor BioScience Corporation
Download detailed PDF Members: Altor BioScience Corporation is a biopharmaceutical company developing a new class of therapeutic products for the treatment of cancer, viral infections and autoimmune diseases. Altor’s drug discovery and therapeutic approaches are based on its patented soluble T-cell antigen receptor (STAR™) and single-chain major histocompatibility complex receptor (MHC) technologies. Altor is employing these novel technologies to improve the safety and efficacy of existing therapeutics. The clinical development strategy of evaluating these drugs in their approved indications will minimize risk and facilitate rapid progress in clinical trials. Altor will use its diverse product portfolio to support internal drug development programs and offer a range of partnership opportunities
This page has been viewed 211 times since April 2007, the link to the organisation's website has been followed 39 times Recent Search Terms used to find this page: altor | . Search for more companies in Miramar Search for more companies in Florida This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Altor BioScience Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|